Research & Development
16 April 2025 - Precision medicine company Renalytix plc (LSE: RENX, OTCQB: RNLXY) on Wednesday announced new clinical data demonstrating the positive impact of its KidneyIntelX test on prescribing pa...
16 April 2025 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) and its partner Eisai Co Ltd (TYO:4523) announced on Wednesday that the European Commission has granted marketing aut...
15 April 2025 - Accord BioPharma Inc, the US specialty division of India-based Intas Pharmaceuticals Ltd, announced on Monday that Intas Pharmaceuticals has completed its acquisition of the UDENYCA (p...
14 April 2025 - Precision medicine oncology company IDEAYA Biosciences Inc (Nasdaq: IDYA) on Monday announced the successful completion of a Type D meeting with the U.S. Food and Drug Administration r...
11 April 2025 - Biopharmaceutical company Halozyme Therapeutics Inc (NASDAQ:HALO) announced on the Thursday that it has received approval from the US Food and Drug Administration (FDA) for its VYVGART...
10 April 2025 - German smart infusion therapy and pain management specialist B. Braun Medical Inc announced on Wednesday that it has received approval from the US Food and Drug Administration (FDA) fo...